Acetylcholinesterase Inhibitors

Medications listed in the tables and non-FDA approved indications included in these retrospective criteria are not indicative of Texas Vendor Drug Program formulary coverage.

  • Revision history
    • July 23, 2021; May 24, 2019; May 2017; June 2015; October 2013; December 2011; January 2010
  • Initially developed
    • April 2006